Impact of Admission Hyperglycemia on Stroke Outcome After Thrombolysis: Risk Stratification in Relation to Time to Reperfusion

Background and Purpose— We evaluated the impact of admission hyperglycemia (HG) on stroke outcome in relation to the timing of reperfusion in patients treated with tissue plasminogen activator (tPA). Methods— We studied 138 consecutive stroke patients with a documented middle cerebral artery (MCA) occlusion treated with intravenous tPA <3 hours of stroke onset. Serum glucose was determined at baseline before tPA administration. HG was defined as a glucose level >140 mg/dL. National Institutes of Health Stroke Scale (NIHSS) scores were obtained at baseline and 24 hour. Transcranial Doppler monitoring of recanalization was conducted during the first 12 hour of stroke onset. mRS was used to assess outcome at 3 months. Results— Median baseline NIHSS score was 17 points. At baseline, 42 (37.3%) patients were hyperglycemic and 96 (62.7%) normoglycemic. Reperfusion was achieved <3 hours of stroke onset in 32 (23%) patients, between 3 to 6 hours in 49 (36%), 6 to 12 hours in 15 (12%), and in 32 (23%) the MCA remained occluded at 12 hours. A logistic regression model revealed that baseline NIHSS score >16 points (odds ratio [OR], 3.32; 95% CI, 2.18 to 24.7; P=0.032) and admission glucose level >140 mg/dL (OR, 5.65; 95% CI, 1.97 to 16.18; P=0.002) independently predicted poor outcome (modified Rankin scale, 3 to 6) at 3 months. After adjusting by age, stroke severity, site of MCA occlusion, and degree of recanalization, the contribution of HG for poor outcome was higher as shorter the time to reperfusion. The highest odds for poor outcome related to HG corresponded to patients who recanalized <3 hour (OR, 3.1; 95% CI, 1.8 to 14.3; P=0.002), as compared with those who recanalized between 3 and 6 hours (OR, 2.1; 95% CI, 1.1 to 16; P=0.034) and between 6 to 12 hours (OR, 1.1; 95% CI, 0.7 to 21; P=0.43). Moreover, baseline glucose level was negatively correlated (r=−0.45; P=0.001) with the degree of improvement in the NIHSS score at 24 hours after early (<3 hours) but not after delayed (>3 hours) or no recanalization. Conclusion— The impact of admission HG on stroke outcome varies depending on the time to tPA-induced reperfusion. The detrimental effect of acute HG is higher after early than after delayed or no reperfusion. Ultra-early glycemic control before reperfusion may improve the efficacy of thrombolytic therapy.

[1]  R. Myers,et al.  Normoglycemia (Not Hypoglycemia) Optimizes Outcome from Middle Cerebral Artery Occlusion , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  R. Bloch,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[3]  C. Pozzilli,et al.  Spontaneous middle cerebral artery reperfusion in ischemic stroke. A follow-up study with transcranial Doppler. , 1995, Stroke.

[4]  M. Kaste,et al.  The European Cooperative Acute Stroke Study (ECASS) , 1993 .

[5]  R. Busto,et al.  Hyperglycemia Increases Infarct Size in Collaterally Perfused but Not End-Arterial Vascular Territories , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  G. Csaba,et al.  Effect of Vitamin D3 Treatment in the Neonatal or Adolescent Age (Hormonal Imprinting) on the Thymic Glucocorticoid Receptor of the Adult Male Rat , 1999, Hormone Research in Paediatrics.

[7]  G. Hankey,et al.  Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative , 2003, The Lancet Neurology.

[8]  L. Shuer,et al.  Effect of hyperglycemia on neuronal changes in a rabbit model of focal cerebral ischemia. , 1990, Stroke.

[9]  References , 1971 .

[10]  J. Sunshine,et al.  Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy , 2004, Stroke.

[11]  R. Anderson,et al.  Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. , 1999, Stroke.

[12]  G. Murray,et al.  Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study , 1997, BMJ.

[13]  M. Kaste,et al.  European Stroke Initiative (EUSI) Recommendations for 
Stroke Management
The European Stroke Initiative Writing Committee , 2000, European journal of neurology.

[14]  Stephen Rose,et al.  Diffusion‐ and perfusion‐weighted MRI response to thrombolysis in stroke , 2002, Annals of neurology.

[15]  T. Brott,et al.  Improved Reliability of the NIH Stroke Scale Using Video Training , 1994, Stroke.

[16]  A. Demchuk,et al.  Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. , 1999, Stroke.

[17]  K. Alberti,et al.  Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). , 1999, Stroke.

[18]  J. Arenillas,et al.  Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator–Treated Patients , 2003, Stroke.

[19]  B. Tranmer,et al.  Insulin reduction of cerebral infarction due to transient focal ischemia. , 1995, Journal of neurosurgery.

[20]  J. Schulte‐Mönting,et al.  Hyperglycemia in Patients with Focal Cerebral Ischemia after Intravenous Thrombolysis: Influence on Clinical Outcome and Infarct Size , 2002, Cerebrovascular Diseases.

[21]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[22]  Mark W Parsons,et al.  Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study , 2002, Annals of neurology.

[23]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[24]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[25]  M. Kaste,et al.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.

[26]  Andrew M. Demchuk,et al.  Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical Practice: The Multicenter rt-PA Acute Stroke Survey , 2002, Circulation.

[27]  V Larrue,et al.  Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. , 1997, Stroke.

[28]  M. Kaste,et al.  Community-Based Thrombolytic Therapy of Acute Ischemic Stroke in Helsinki , 2003, Stroke.

[29]  R. Roine,et al.  Hyperglycemia in Acute Stroke , 2004, Stroke.

[30]  H. Gerstein,et al.  Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview , 2001, Stroke.

[31]  J. Woo,et al.  The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. , 1990, Archives of neurology.

[32]  R. Busto,et al.  Moderate Hyperglycemia Worsens Acute Blood‐Brain Barrier Injury After Forebrain Ischemia in Rats , 1993, Stroke.

[33]  J. Alger,et al.  Beyond Mismatch: Evolving Paradigms in Imaging the Ischemic Penumbra With Multimodal Magnetic Resonance Imaging , 2003, Stroke.

[34]  H. Adams,et al.  Acute blood glucose level and outcome from ischemic stroke , 1999, Neurology.

[35]  H. Schouten,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[36]  J. Broderick,et al.  Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial , 2002, Neurology.

[37]  A. Alexandrov,et al.  Transcranial doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke. , 2000, Stroke.

[38]  P. Chan,et al.  Spreading depression-induced gene expression is regulated by plasma glucose. , 1999, Stroke.

[39]  K. Butcher,et al.  Insular Cortical Ischemia Is Independently Associated With Acute Stress Hyperglycemia , 2004, Stroke.

[40]  F. Plum,et al.  Moderate hyperglycemia augments ischemic brain damage , 1982, Neurology.